NEW YORK, June 21 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
This comprehensive worldwide study is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the coagulation market during the next decade. The study explores business and technological trends in major markets; provides estimates of the test volume, instrument placements and installed base; as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.
Contains 650 pages and 150 tables
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
The report will present comprehensive analyses of the coagulation markets in the following countries:
In addition to seven countries, a worldwide market overview of the coagulation market will be provided. The analysis of each country will include the following information:
Business Dynamics and Trends
The major issues pertaining to the coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years will be explored for each of the seven countries.
Major Market Segments
Physician Offices/Group Practices
The hospital market will be further segmented by bed size; commercial/private laboratory market by sample volume; and physician office market by practice size and physician specialty.
Test Volume and Sales Projections, 2008-2018
The 2008, 2013 and 2018 test volume forecasts for over 40 major coagulation procedures, segmented by country and testing location, will be developed. For each country and market segment, the study will also provide typical coagulation daily work load. In addition, the report will present an overview of the clinical significance and market needs for major coagulation laboratory tests, including:
Factors II, V/Leiden, VII, VIII, IX, IXa, X, Xa, XI, XII, XIII and others
Ethanol Flocculation • Hirudin
Plasminogen Activator Inhibitor
Platelet Function Tests
Proteins C and S
Prothrombin Fragment 1.2
Von Willebrand's Factor, and others
The 2008 Instrument Placements and Installed Base
For major automated and semiautomated coagulation systems, the report will provide the 2008 estimates of their unit placements and total installed base, by supplier and model. A review of the current instrumentation technologies and feature comparison of nearly 50 leading automated analyzers will be also presented.
Market Size and Growth, 2008-2018
For each country and market segment, the report will present estimates of the reagent and instrument sales for 2008, 2013 and 2018.
The 2008 Market Share Analysis
The 2008 sales and market share estimates will be provided for leading reagent and instrument suppliers, by country.
A detailed analysis of the following technologies and their potential market applications will be developed.
Monoclonal and Polyclonal Antibodies
Biosensors, and others
Market Needs and Challenges
The report will identify the major opportunities for coagulation instruments and consumables during 2009-2019, and propose "ideal" product models with tentative prices and operating characteristics.
The major current and emerging suppliers of coagulation products will be analyzed in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
HemoSense/Inverness Medical Innovations
ZyCare, and others
Business Opportunities and Strategic Recommendations For Instrument and Reagent Suppliers
Specific product development and business expansion opportunities • Potential market entry barriers and risks
Alternative market penetration strategies • Business planning issues and concerns
To order this report:
Intl: +1 805-652-2626